SCHEMBL7214542

SCHEMBL7214542

Clc1ccc2c(N3CCN(CCC4Cc5ccccc5C4)CC3)c[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.53
DRD3 P35462 5/20 0.53
HTR1A P08908 2/20 0.53
DRD4 P21917 2/20 0.53
HTR2A P28223 2/20 0.53
HTR2C P28335 2/20 0.53
HTR7 P34969 2/20 0.53
DRD1 P21728 2/20 0.48
AVPR1A P37288 1/20 0.44
SLC6A4 P31645 3/20 0.42
SLC6A2 P23975 2/20 0.42
HTR1D P28221 1/20 0.41
HTR1B P28222 1/20 0.41
KCNH2 Q12809 3/20 0.39
HTR6 P50406 2/20 0.39
CYP3A4 P08684 1/20 0.39
CHRM1 P11229 1/20 0.39
OPRK1 P41145 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7214544 0.89 AVPR1A (0.46) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL7216932 0.83 OPRM1 (0.54) DRD2SLC6A4OPRK1
SCHEMBL7214469 0.79 HTR1D (0.57) DRD2HTR1AHTR2AHTR7SLC6A4
SCHEMBL7215981 0.78 DRD3 (0.53) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL7220008 0.77 ADRA1D (0.55) SLC6A4OPRK1
SCHEMBL7215864 0.76 ADRA1D (0.54) SLC6A4OPRK1
SCHEMBL7214607 0.75 DRD2 (0.58) DRD2HTR1ADRD4HTR2AAVPR1A
SCHEMBL7220048 0.74 DRD2 (0.60) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL7214300 0.74 DRD2 (0.56) DRD2HTR1AHTR7SLC6A4HTR1D
SCHEMBL7213683 0.73 DRD2 (0.57) DRD2HTR1AHTR7SLC6A4HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552044-B2 Dopamine receptors H. LUNDBECK A/S (DK) 2003-04-22 US disclosed
EP-0946542-B1 INDANE OR DIHYDROINDOLE DERIVATIVES LUNDBECK & CO AS H (DK) 2002-10-09 EP disclosed
US-6352988-B2 HIGH AFFINITY FOR D4 RECEPTORS; TREATMENT OF SCHIZOPHRENIA, OTHER PSYCHOSES, ANXIETY DISORDERS, DEPRESSION, ALCOHOL ABUSE, IMPULSE CONTROL DISORDERS, AGGRESSION H. LUNDBECK A/S (DK) 2002-03-05 US disclosed
US-20010021777-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-13 US disclosed
US-20010020095-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-06 US disclosed
US-6262087-B1 HAVE HIGH AFFINITY FOR D4 RECEPTORS; USEFUL IN THE TREATMENT OF CERTAIN PSYCHIATRIC AND NEUROLOGIC DISORDERS, INCLUDING PSYCHOSIS, DEPRESSION AND ANXIETY. H. LUNDBECK A/S (DK) 2001-07-17 US disclosed
EP-0946542-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP disclosed
WO-1998028293-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H.LUNDBECK A/S (DK) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020095-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 DRD2 14/4885DRD3 30/4885HTR1A 5/4885
US-20010021777-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 DRD2 14/4885DRD3 30/4885HTR1A 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.